CYRX
CYRX
NASDAQ · Life Sciences Tools & Services

Cryoport Inc

$8.72
+0.12 (+1.40%)
As of Feb 8, 1:54 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +70.0% upside
Low Target $10.29
Average Target $14.82
High Target $21.75
Current Price $8.72
Current
$8.72
Target
$14.82
$10.29 $14.82 avg $21.75
Scenario Analysis
Bear Case
$10.29
18.0%
Low target
Base Case
$14.82
+70.0%
Avg target
Bull Case
$21.75
+149.4%
High target
Risk/Reward
8.3x
Highly favorable
Price in Context
52-Week High
$11.45
-23.8% from high
52-Week Low
$4.58
+90.4% from low
Target vs 52W High
$14.82
+29.4% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
13d
until earnings
EPS Est: $-0.21
Earnings in 13 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 82% $369.21 -32.0%
DHR
Danaher Corp
Strong Buy 31 87% $158.11 -25.6%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -50.1%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -55.8%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -87.6%
WAT
Waters Corp
Buy 25 56% $189.60 -50.3%
ILMN
Illumina Inc
Hold 26 50% $169.36 +41.5%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -45.3%